Immunotherapy Part 2: Common Controversies

This episode is part 2 of the Immunotherapy Series, which reviews common controversies affecting daily use of immune checkpoint inhibitors (ICIs) in the clinic, such as treatment options for immune related adverse effects beyond corticosteroids, re-challenging after toxicity, use of ICIs in patients with auto-immune conditions, and drug interactions.

Moderator:
Karin K. Shih, MD
Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell

Speakers:
Erin Zacholski, PharmD, BCOP
Assistant Professor - VCU School of Pharmacy
Clinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer Center

Sarah Hayward, PharmD, BCOP
Clinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

Keywords: immunotherapy, toxicities, immunotherapy toxicities, immune-related adverse events, high-grade toxicities

Target Audience

 All SGO Members

You may also be interested in

Immunotherapy Part 1: Basics of Immune-Related Adverse Events
This episode is part 1 of the Immunotherapy podcast series, which reviews immune-checkpoint inhibitors encountered in the gynecologic oncology setting, common immunotherapy toxicities and patient counseling on them, as well as the basic treatment course for patients with high-grade toxicities.
Immunotherapy Part 3: Common Controversies and Remaining Questions
This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies.
Course summary
Course opens: 
03/12/2024
Course expires: 
03/12/2029
Cost:
$0.00
Rating: 
0

Price

Cost:
$0.00
Please login or register to take this course.